The stem cell face cream is to be sold wholesale to major cosmetic distributors worldwide; focusing on the US and EU.
Stem Cell Therapy International will soon be known as AmStem International after a successful merger with Histostem of South Korea.
David Stark, president of AmStem, said: “This will launch AmStem into the multi billion dollar annual wholesale cosmetic market. It will also provide an influx of capital to our new business, to provide a boost for launching our plans for expansion in other areas.”